Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04186884 · ClinicalTrials.gov registry record
Caregiver Burden, Quality of Life, and Symptom Distress at Different Palliative Cancer Care Settings
A clinical trial of Advanced Malignant Neoplasm and Metastatic Malignant Neoplasm, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- 351
- Enrollment target
- 1
- Study location
NCT04186884: Completed study of Advanced Malignant Neoplasm and Metastatic Malignant Neoplasm, sponsored by M.D. Anderson Cancer Center.
NCT04186884 is a study of Advanced Malignant Neoplasm and Metastatic Malignant Neoplasm that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 351 participants, above the 154-participant average among 16 other Advanced Malignant Neoplasm trials with a reported enrollment target (128% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04186884, a study of Advanced Malignant Neoplasm and Metastatic Malignant Neoplasm, has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- 351 participants
- Enrollment target
- 1
- Study location
Study Summary
This trial studies caregiver burden, quality of life, and symptom distress of patients and their informal (unpaid) caregivers at different palliative care settings. Cancer caregiving may affect a caregiver's life physically, emotionally, socially, and financially. Studying caregiver burden may help investigators learn about caregivers' opinions on stress of caregiving, and about the factors related to caregiver burdens.
Primary Outcome
Measured by the Montgomery-Borgatta Caregiver Burden Scale. (4-item sub-scale questionnaire to measure the degree caregivers perceive their tasks and evaluates emotional effects of caregiving has a (Cronbach Alpha ranging from 0.68 to 0.82.)
Conditions Studied
Interventions
- OTHER Quality-of-Life Assessment
- OTHER Questionnaire Administration
Study Locations (1)
Texas
- M D Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 351 participants |
| Start Date | 2019-03-26 |
| Est. Completion | 2021-11-05 |
What the finished NCT04186884 record still lists
NCT04186884 is an observational study that tracks outcomes without assigning an intervention. The registered 351 participants enrollment target is mid-sized for trials with a published cap, above the 154-participant average among 16 other Advanced Malignant Neoplasm trials with a reported enrollment target (128% higher).
The record links to 4 conditions, with Advanced Malignant Neoplasm appearing as the primary indexed condition, and to 2 interventions - of which Quality-of-Life Assessment is the first listed.
NCT04186884 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT04186884 about?
NCT04186884 is a clinical study titled "Caregiver Burden, Quality of Life, and Symptom Distress at Different Palliative Cancer Care Settings". This trial studies caregiver burden, quality of life, and symptom distress of patients and their informal (unpaid) caregivers at different palliative care settings. Cancer caregiving may affect a caregiver's life physically, emotionally, socially, and financially. Studying caregiver burden may help ...
What is the current status of trial NCT04186884?
This trial is currently completed. The enrollment target is 351 participants. The study started on 2019-03-26. Estimated completion is 2021-11-05.
What conditions does trial NCT04186884 study?
This clinical trial studies the following conditions: Advanced Malignant Neoplasm, Metastatic Malignant Neoplasm, Locally Advanced Malignant Neoplasm, Recurrent Malignant Neoplasm.
What interventions are being tested in trial NCT04186884?
The interventions under investigation include: Quality-of-Life Assessment (OTHER), Questionnaire Administration (OTHER).
Who is sponsoring clinical trial NCT04186884?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04186884 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Advanced Malignant Neoplasm
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04186884's enrollment target sits among peer trials
351 2nd of 16 the highest of 16 other Advanced Malignant Neoplasm trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Advanced Malignant Neoplasm trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
RECRUITING · Phase 1
-
First in Human Study of Ziftomenib in Relapsed or Refractory Acute Myeloid Leukemia
RECRUITING · Phase 1
-
A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies
RECRUITING · Phase 1
-
Preference of Room Setting and Waiting Time in Patients With Advanced, Locally Advanced, or Metastatic Cancer and Their Caregivers Who Are Seen in the Outpatient Supportive/Palliative Care Center
ACTIVE NOT RECRUITING · NA
-
A Study of Cancer Related Fatigue in Patients With Metastatic Cancer Receiving Anti-PD1 Immunotherapy
ACTIVE NOT RECRUITING · Phase 3
-
Cordotomy in Reducing Pain in Patients With Advanced Cancer
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06241456 · 351 participants · Phase 1
FT825/ONO-8250, an Off-the-Shelf, HER2 CAR-T, With or Without Monoclonal Antibodies in Advanced Solid Tumors
- NCT06576726 · 351 participants
Sensorimotor and Psychosocial Trajectories in Adolescents With Tic Disorder
- NCT07043400 · 351 participants · Phase 3
A Study to Investigate Tislelizumab Administered as Subcutaneous Injection Versus Intravenous Infusion Plus Chemotherapy in Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
- NCT07261423 · 351 participants · NA
Pollution Intervention to Impact Kids Asthma Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI